Detalhe da pesquisa
1.
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a review.
Future Oncol
; 17(1): 91-102, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33463373
2.
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer.
BJU Int
; 121(2): 203-208, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370882
3.
Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation.
PLoS One
; 14(8): e0221816, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469859